DexCom Inc 2024 SR
The report highlights Dexcom's commitment to expanding access to biosensing technology, specifically with the launch of Stelo, the first over-the-counter glucose biosensor in the U.S. The company advanced its sustainability reporting by obtaining third-party limited assurance for its greenhouse gas emissions inventory for the first time. Key achievements include a 40% reduction in injury rates and significant progress in pay equity, with women and diverse employees earning 99% of the pay of their peers in similar roles. Dexcom also expanded its manufacturing footprint with a new facility in Ireland and integrated renewable energy at its Malaysia site.
Company: DexCom Inc
Sector: Information Information Technology
Country: United States
Year: 2024
Type: SR
Pages: 96
DexCom Inc
Sustainability Report
The report highlights Dexcom's commitment to expanding access to biosensing technology, specifically with the launch of Stelo, the first over-the-counter glucose biosensor in the U.S. The company advanced its sustainability reporting by obtaining third-party limited assurance for its greenhouse gas emissions inventory for the first time. Key achievements include a 40% reduction in injury rates and significant progress in pay equity, with women and diverse employees earning 99% of the pay of their peers in similar roles. Dexcom also expanded its manufacturing footprint with a new facility in Ireland and integrated renewable energy at its Malaysia site.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Workplace Fatalities
Employees